Arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Area of Science:

• Cardiology
• Genetics
• Inherited Diseases

Background:

• Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is a primary inherited cardiomyopathy.
• It is characterized by ventricular arrhythmias and a significant risk of sudden cardiac death.
• Diagnosis relies on established criteria including electrical and structural cardiac assessments, alongside genetic mutation analysis.

Purpose of the Study:

• To summarize the key aspects of diagnosing and managing arrhythmogenic right ventricular dysplasia/cardiomyopathy.
• To highlight the role of genetic analysis in ARVC diagnosis.
• To emphasize the importance of therapeutic interventions and risk stratification for sudden cardiac death.

Main Methods:

• Review of diagnostic criteria for ARVC.
• Analysis of current pharmacological therapies.
• Consideration of implantable defibrillator therapy for risk prevention.
• Evaluation of environmental factors, particularly exercise, in disease progression.

Main Results:

• ARVC diagnosis integrates clinical, electrical, and structural findings with genetic data.
• Management strategies include pharmacotherapy and device-based prevention of sudden cardiac death.
• Exercise is a critical environmental factor influencing ARVC development and progression.

Conclusions:

• Accurate diagnosis of ARVC requires a multi-faceted approach combining clinical evaluation and genetic testing.
• Effective management of ARVC patients involves tailored medical treatments and consideration of implantable defibrillators.
• Understanding the impact of environmental factors like exercise is crucial for managing ARVC progression and patient outcomes.